Explore the full record of transactions filed by Tahir Misbah, Chief Financial Officer. Director active across 1 companies, notably IGM Biosciences, Inc.. Cumulatively, 10 disclosures have been published. Total volume traded: €15k. The latest transaction was disclosed on 26 May 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Misbah Tahir is the Chief Financial Officer at IGM Biosciences, Inc. He is responsible for the financial management of the company, overseeing financial operations to ensure its growth.